<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Hospitalized <z:hpo ids='HP_0011009'>acute</z:hpo> decompensated <z:hpo ids='HP_0001635'>heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ADHF</z:e>) patients have high risk of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> (TE) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study is to determine the short-term prognostic value of TE for different thrombotic biomarkers (fibrinogen; D-dimer; tissue plasminogen activator antigen, t-PA; and plasminogen-activator inhibitor type 1 antigen, PAI-1) and left ventricle echocardiographic characteristics (diastolic diameter, LVDD; ejection fraction, LVEF) in admitted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ADHF</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We included 140 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ADHF</z:e> in NYHA classes III-IV (October 2009 to November 2011) </plain></SENT>
<SENT sid="3" pm="."><plain>Subjects with <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> drugs, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, or <z:mp ids='MP_0005048'>thrombosis</z:mp> were excluded </plain></SENT>
<SENT sid="4" pm="."><plain>Biochemical and echocardiographic data were obtained within 12h after admission and <z:hpo ids='HP_0000001'>all</z:hpo> patients were given enoxaparin 40 mg/day </plain></SENT>
<SENT sid="5" pm="."><plain>Throughout hospitalization (median, 11 days), 14 subjects (10.0%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ADHF</z:e> received a TE diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002204'>Pulmonary embolism</z:hpo> (PE, 5.0%), <z:hpo ids='HP_0002625'>deep-vein thrombosis</z:hpo> (DVT, 7.1%), or a combination of these were confirmed in 3, 6 and 4 patients respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> was diagnosed in 1 subject (0.7%) associated with left ventricular intracavitary <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> developed after admission </plain></SENT>
<SENT sid="8" pm="."><plain>The following determinations most strongly predicted the short-term risk of TE: fibrinogen&gt;500 mg/dL (Odds Ratio [OR] 6.19; p=.0019), D-dimer&gt;600 ng/dL (OR 7.84; p=.0009), t-PA&gt;10 ng/dL (OR 7.22; p=.0007), PAI-1&gt;30 ng/dL (OR 8.70; p&lt;.0006), LVDD&gt;50mm (OR 5.67; p=.0039), and LVEF&lt;30% (OR 5.48; p=.0163) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Elevated levels of fibrinogen, D-dimer, t-PA and PAI-1 antigens as well as a <z:mp ids='MP_0002753'>dilated left ventricle</z:mp> with poor systolic function determined at admission are associated with a significantly high short-term risk of TE </plain></SENT>
</text></document>